Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient

Transpl Infect Dis. 2016 Oct;18(5):768-772. doi: 10.1111/tid.12577. Epub 2016 Sep 7.

Abstract

Trichosporon is an ubiquitous yeast that has emerged as an opportunistic pathogen in the immunocompromised host. We describe a case of invasive trichosporonosis in an allogeneic hematopoietic stem cell transplant (allo-HSCT) recipient while on caspofungin antifungal prophylaxis. She developed disseminated trichosporonosis in the pre-engraftment period and was successfully treated with voriconazole. She later developed 2 further episodes of invasive trichosporonosis involving the central nervous system. This case highlights the challenges of managing trichosporonosis in allo-HSCT recipients and suggests the need for lifelong therapy in some patients.

Keywords: Trichosporon asahii; aplastic anemia; central nervous system infection; hematopoietic stem cell transplant; hydrocephalus; trichosporonosis.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic / therapy*
  • Antibiotic Prophylaxis / methods*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Caspofungin
  • Central Nervous System / diagnostic imaging
  • Central Nervous System / microbiology*
  • Echinocandins / administration & dosage
  • Echinocandins / therapeutic use
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Hydrocephalus / etiology
  • Hydrocephalus / surgery
  • Immunocompromised Host
  • Immunosuppression Therapy / adverse effects
  • Laminectomy
  • Lipopeptides / administration & dosage
  • Lipopeptides / therapeutic use
  • Magnetic Resonance Imaging
  • Opportunistic Infections / cerebrospinal fluid
  • Opportunistic Infections / complications
  • Opportunistic Infections / drug therapy*
  • Opportunistic Infections / microbiology
  • Recurrence
  • Transplantation, Autologous
  • Treatment Outcome
  • Triazoles / administration & dosage
  • Triazoles / therapeutic use
  • Trichosporon / isolation & purification*
  • Trichosporonosis / cerebrospinal fluid
  • Trichosporonosis / complications
  • Trichosporonosis / drug therapy*
  • Trichosporonosis / microbiology
  • Ventriculoperitoneal Shunt
  • Voriconazole / administration & dosage
  • Voriconazole / therapeutic use

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Triazoles
  • posaconazole
  • Caspofungin
  • Voriconazole